Where does Cisbio Bioassays rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cisbio Bioassays ranks #31,214 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cisbio Bioassays hold?

Cisbio Bioassays holds 8 US utility patents granted between 2016 and 2025, spanning 8 technology areas.

What is Cisbio Bioassays's Innovation Score?

Cisbio Bioassays has an Innovation Score of 28.2 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cisbio Bioassays's patent grant rate increasing or decreasing?

Cisbio Bioassays's recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cisbio Bioassays's patents?

Cisbio Bioassays's patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cisbio Bioassays patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cisbio Bioassays

Q: What technology areas does Cisbio Bioassays focus on?

Cisbio Bioassays's top technology area is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium) with 5 patents, ranking #326 of 1,317 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cisbio ranks #31,214 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#31,214
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.2/100): 14.0
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31214 · Foreign Corporation #31,214 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,214/49,997
PHOTO-FINISH Chunghwa Chemical…
CPC-NARROW C07F · 8 areas
INNOV-THIN 28.2/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chunghwa Chemical Synthesis & Biotech Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cisbio’s 28.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (27%) Velocity 2.2 pts (8%) Breadth 10.0 pts (35%) Claim depth 8.4 pts (30%)

Qualcomm Incorporated · highest

85
Cisbio Bioassays · this assignee

28
3D Lighting… · lowest

7

What this shows Cisbio's Innovation Score is 28.2/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cisbio?

Each dot is one of Cisbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cisbio’s own 14.0 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cisbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cisbio's grants concentrate

Cisbio Bioassays is a focused PatentsView assignee: 8 CPC subclasses with 62.5% of grants classified under C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2016. By volume, Cisbio sits between Chunghwa Chemical Synthesis & Biotech Co. Ltd. and Cleantek Industries Inc..

Cisbio's three-year grant acceleration

Cisbio Bioassays shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Chunghwa Chemical…

8
Cimc Containers H…

8
Cinna

8
Cireca Theranosti…

8
Claronav

8
Class AND Culture

8
Clean Planet

8
Cleantek Industri…

8
Cisbio Bioassays ◀

8

What this shows Cisbio holds 8 patents at rank #31,170, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cisbio

By rank, the assignees closest to #31,170 in granted patent volume.

Leaders in C07F (Acyclic)

Other assignees with the most granted patents in Cisbio's primary technology class.

Cisbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cisbio Bioassays patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	12.5%
2018	2	25.0%
2019	2	25.0%
2020	1	12.5%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does Cisbio Bioassays patent most?

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

C07D - Heterocyclic Compounds 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 2

C07K - Peptides 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cisbio Bioassays's patent record in context - here's where to go next.

Cisbio Bioassays's lead technology class is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium), 62.5% of its portfolio - see every assignee active in that class. Explore C07F
Ranked #31,214 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cisbio Bioassays against Chunghwa Chemical Synthesis & Biotech Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.